News Feature
Nature Biotechnology 25, 1379 - 1381 (2007)
doi:10.1038/nbt1207-1379
Hepatitis C: staying the course
Ken Garber1
- Ann Arbor, Michigan
Abstract
A rash of failures for hepatitis C drugs, conflicting theories about the immune system's role and the looming issue of drug resistance make it impossible to predict when or how new therapies will make an impact. Ken Garber reports.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Hepatitis HCV variability, the immune system and resistance to antiviral drugsNature Reviews Gastroenterology & Hepatology News and Views (01 Jul 2009)
Hepatitis C The role of new interferons in the era of STAT-CNature Reviews Gastroenterology & Hepatology News and Views (01 Sep 2009)
See all 4 matches for News And Views

